Estrogen receptor-mediated, nitric oxide-dependent modulation of the immunologic barrier function of the endothelium regulation of fas ligand expression by estradiol

Circulation

Volumn 104, Issue 21, 2001, Pages 2576-2581

  Amant, Carole ^a   Holm, Pernille ^b   Xu, Shu Hua ^a   Tritman, Neil ^a   Kearney, Marianne ^a   Losordo, Douglas W ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Atherosclerosis; Cells; Coronary disease; Endothelium

Indexed keywords

CHOLESTEROL; DRINKING WATER; ESTRADIOL; ESTROGEN RECEPTOR; FAS LIGAND; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOWN REGULATION; FEMALE; HORMONAL REGULATION; IMMUNITY; INFLAMMATORY CELL; LEUKOCYTE MIGRATION; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIUM;

EID: 0035923483     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4601.099406     Document Type: Article

References (30)

1. The protective effects of estrogen on the cardiovascular system
2. Estrogen receptor-mediated inhibition of human endothelial cell apoptosis: Estradiol as a survival factor
3. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: Lack of an effect of added progesterone
4. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury
5. Estrogen inhibits the response-to-injury in a mouse carotid artery model
6. Estradiol accelerates functional endothelial recovery after arterial injury
7. Estrogen inhibits the vascular injury response in estrogen receptor-deficient mice
8. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: Possible mechanisms for gender differences in atherosclerosis
9. TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation
10. Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow-restricted vessels
11. Antiatherogenic effect of estrogen abolished by balloon catheter injury in cholesterol-clamped rabbits
12. The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium: A time course study in cholesterol-clamped rabbits
13. Effect of estrogen replacement therapy on development of experimental arteriosclerosis: A study in transplanted and balloon-injured rabbit aortas
14. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression
15. Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-α-induced apoptosis
16. Fas ligand in human serum
17. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing
18. Apoptosis by death factor
19. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
20. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium
21. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene
22. Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells
23. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
24. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling
25. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment
26. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
27. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells
28. Estradiol suppresses MCP-1 expression in vivo: Implications for atherosclerosis
29. HERS: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
30. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis